Lv1
60 积分 2022-05-11 加入
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia
1个月前
已完结
Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial
2个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2个月前
已完结
Membranous Nephropathy: Updates on Management
4个月前
已完结
Podocytopathies
4个月前
已完结
To B or Not to B — the Role of B-Cell Depletion in Lupus Nephritis
4个月前
已完结
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
4个月前
已完结
Cytokine storm
4个月前
已完结
How I Treat Challenging Cases of Antibody-Mediated Glomerular Diseases
7个月前
已完结
皖公网安备34019202002308
